Results 311 to 320 of about 363,488 (344)
Some of the next articles are maybe not open access.

Spinimmunoassay of progesterone

Biochemical and Biophysical Research Communications, 1975
Abstract A spin-labeled derivative of progesterone was prepared: 3(progesterone-1111α-hemisuccinyl)-3 methylamino-2,2,5,5, tetramethyl pyrolidine-1-oxyl. A corresponding antibody was produced by inoculating rabbits with progesterone-11α-hemisuccinyl-(bovine serum albumin). These materials were then used in developing a method to measure progesterone.
Robert Wei, Ramona Almirez
openaire   +3 more sources

Progesterone and ovulation

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
The role of progesterone (P) in the mechanism of ovulation is controversial at best. The contraceptive application of P was established in rodents in 1936 and with orally absorbed progestogenes was put to human use. There were hints on the proovulatory actions of P administered before the time of ovulation in rats by 1948.
openaire   +3 more sources

Novel Mechanisms of Progesterone Antagonists and Progesterone Receptor

Journal of the Society for Gynecologic Investigation, 2000
The progesterone receptor (PR), as a member of the nuclear receptor superfamily of ligand-dependent transcription factors, activates gene transcription through binding to specific palindromic progesterone response elements (PRE) in the promoter region of progestin-responsive genes.
Susan A. Leonhardt   +2 more
openaire   +3 more sources

Progesterone receptor and the mechanism of action of progesterone antagonists

The Journal of Steroid Biochemistry and Molecular Biology, 1995
Currently available progesterone antagonists have been suggested to fall into two categories based on differences in how they interact with and inactivate the progesterone receptor (PR). The anti-progestin ZK98299 (Type I) impairs PR association with DNA, while Type II compounds (RU486, ZK112993, ZK98734) promote PR binding to DNA.
Angelo M. DeMarzo   +5 more
openaire   +3 more sources

The Case for Progesterone

Annals of the New York Academy of Sciences, 2005
Abstract: Recent clinical trials in hormone therapy (HT) for women approaching or past menopause have been disappointing. Most women who have been taking conjugated equine estrogens combined with synthetic progestins have been encouraged to stop these supplements because of increased health risks.
openaire   +3 more sources

PROGESTERONE IN BLOOD

Journal of Endocrinology, 1958
SUMMARY The content of progesterone was determined in the peripheral venous blood of cows from the 32nd day of pregnancy until the day before calving. The level ranged from 0·74 to 0·98 μg progesterone/100 ml. plasma throughout the 32nd-256th day period, but thereafter a marked decrease was observed, and on the day before calving the level ...
openaire   +6 more sources

The Biochemistry of Progesterone

1964
Publisher Summary This chapter focuses on the progress that has been made in the knowledge of certain aspects of the biochemistry of progesterone in the past few years. The chapter discusses the secretion and metabolism of the hormone. The primary biological action of progesterone is on reproductive processes.
openaire   +3 more sources

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Archives of Pathology & Laboratory Medicine, 2010
M. E. Hammond   +31 more
semanticscholar   +1 more source

Physiology of Progesterone

2015
The major target organ of progesterone is the reproductive system. Progesterone, in association with estrogen, is involved in the development and sexual maturation of the reproductive organs and orchestrates the menstrual cycle. Progesterone takes part in all the processes from the preparation of the uterine decidua, myometrium and cervix during the ...
Edi Vaisbuch, Offer Erez, Roberto Romero
openaire   +2 more sources

Progesterone antagonists and progesterone receptor modulators: an overview

Steroids, 2003
Since the original description of the structure of the antiprogestin, mifepristone, was published, numerous related compounds have been synthesized which may function as progesterone antagonists (PAs) or progesterone receptor modulators (PRMs). The latter are mixed agonists-antagonists.
openaire   +3 more sources

Home - About - Disclaimer - Privacy